|
1
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen JG, Chen HZ, Zhu J, Yang YL, Zhang
YH, Huang PX, Chen YS, Zhu CY, Yang LP, Shen K, et al: Cancer
survival in patients from a hospital-based cancer registry, China.
J Cancer. 9:851–860. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Varghese C and Shin HR: Strengthening
cancer control in China. Lancet Oncol. 15:484–485. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song JL, Chen C, Yuan JP and Sun SR:
Progress in the clinical detection of heterogeneity in breast
cancer. Cancer Med. 5:3475–3488. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zardavas D, Irrthum A, Swanton C and
Piccart M: Clinical management of breast cancer heterogeneity. Nat
Rev Clin Oncol. 12:381–394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Parker JS, Mullins M, Cheang MC, Leung S,
Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, et al:
Supervised risk predictor of breast cancer based on intrinsic
subtypes. J Clin Oncol. 27:1160–1167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tibshirani R, Hastie T, Narasimhan B and
Chu G: Diagnosis of multiple cancer types by shrunken centroids of
gene expression. Proc Natl Acad Sci USA. 99:6567–6572. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brott BK and Sokol SY: Regulation of
Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol
Cell Biol. 22:6100–6110. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shao YC, Wei Y, Liu JF and Xu XY: The role
of Dickkopf family in cancers: From Bench to Bedside. Am J Cancer
Res. 7:1754–1768. 2017.PubMed/NCBI
|
|
11
|
Aguilera O, Fraga MF, Ballestar E, Paz MF,
Herranz M, Espada J, García JM, Muñoz A, Esteller M and
González-Sancho JM: Epigenetic inactivation of the Wnt antagonist
DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene.
25:4116–4121. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu J, Zhang S, Gu L and Di W: Epigenetic
silencing of DKK2 and Wnt signal pathway components in human
ovarian carcinoma. Carcinogenesis. 33:2334–2343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu XY, Xia P, Yu M, Nie XC, Yang X, Xing
YN, Liu YP, Takano Y and Zheng HC: The roles of REIC gene and its
encoding product in gastric carcinoma. Cell Cycle. 11:1414–1431.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hirata H, Hinoda Y, Majid S, Chen Y, Zaman
MS, Ueno K, Nakajima K, Tabatabai ZL, Ishii N and Dahiya R:
DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling
pathway while inhibiting the Wnt-canonical pathway in human renal
cell carcinoma. Cancer. 117:1649–1660. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ringnér M, Fredlund E, Häkkinen J, Borg Å
and Staaf J: GOBO: Gene expression-based outcome for breast cancer
online. PLoS One. 6:e179112011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Szász AM, Lánczky A, Nagy Á, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The Cancer Genome Atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.
|
|
19
|
Koboldt DC, Fulton RS, McLellan MD,
Schmidt H, Kalicki-Veizer J, McMichael JF, Fulton LL, Dooling DJ,
Ding L, Mardis ER, et al: Cancer Genome Atlas Network:
Comprehensive molecular portraits of human breast tumours. Nature.
490:61–70. 2012. View Article : Google Scholar
|
|
20
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBio-Portal. Sci Signal. 6:pl12013. View Article : Google Scholar
|
|
21
|
Curtis C, Shah SP, Chin SF, Turashvili G,
Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et
al: METABRIC Group: The genomic and transcriptomic architecture of
2,000 breast tumours reveals novel subgroups. Nature. 486:346–352.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pereira B, Chin SF, Rueda OM, Vollan HK,
Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ,
et al: The somatic mutation profiles of 2,433 breast cancers
refines their genomic and transcriptomic landscapes. Nat Commun.
7:114792016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar
|
|
24
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–D452. 2015. View Article : Google Scholar
|
|
25
|
Agapito G, Guzzi PH and Cannataro M:
Visualization of protein interaction networks: Problems and
solutions. BMC Bioinformatics. 14(Suppl 1): S12013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Benito-Martin A and Peinado H: FunRich
proteomics software analysis, let the fun begin! Proteomics.
15:2555–2556. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
The Gene Ontology: Consortium: Expansion
of the Gene Ontology knowledgebase and resources. Nucleic Acids
Res. 45:D331–D338. 2017. View Article : Google Scholar
|
|
28
|
Mu J, Hui T, Shao B, Li L, Du Z, Lu L, Ye
L, Li S, Li Q, Xiao Q, et al: Dickkopf-related protein 2 induces
G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin
signaling and is frequently methylated in breast cancer.
Oncotarget. 8:39443–39459. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Duffy MJ, Synnott NC, McGowan PM, Crown J,
O'Connor D and Gallagher WM: p53 as a target for the treatment of
cancer. Cancer Treat Rev. 40:1153–1160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu M, Liu X, Xu Y, Zhu S and Gao Y: Co
expression of Axin and APC gene fragments inhibits colorectal
cancer cell growth via regulation of the Wnt signaling pathway. Mol
Med Rep. 16:3783–3790. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim DH, Suh J, Surh YJ and Na HK:
Regulation of the tumor suppressor PTEN by natural anticancer
compounds. Ann NY Acad Sci. 1401:136–149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stephens PJ, Tarpey PS, Davies H, Van Loo
P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell
GR, et al: Oslo Breast Cancer Consortium (OSBREAC): The landscape
of cancer genes and mutational processes in breast cancer. Nature.
486:400–404. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hall CL, Daignault SD, Shah RB, Pienta KJ
and Keller ET: Dickkopf-1 expression increases early in prostate
cancer development and decreases during progression from primary
tumor to metastasis. Prostate. 68:1396–1404. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu WH, Liu ZB, Yang C, Qin W and Shao ZM:
Expression of dickkopf-1 and beta-catenin related to the prognosis
of breast cancer patients with triple negative phenotype. PLoS One.
7:e376242012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bu G, Lu W, Liu CC, Selander K, Yoneda T,
Hall C, Keller ET and Li Y: Breast cancer-derived Dickkopf1
inhibits osteoblast differentiation and osteoprotegerin expression:
Implication for breast cancer osteolytic bone metastases. Int J
Cancer. 123:1034–1042. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rachner TD, Göbel A, Thiele S, Rauner M,
Benad-Mehner P, Hadji P, Bauer T, Muders MH, Baretton GB, Jakob F,
et al: Dickkopf-1 is regulated by the mevalonate pathway in breast
cancer. Breast Cancer Res. 16:R202014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Veeck J, Bektas N, Hartmann A, Kristiansen
G, Heindrichs U, Knüchel R and Dahl E: Wnt signalling in human
breast cancer: Expression of the putative Wnt inhibitor Dickkopf-3
(DKK3) is frequently suppressed by promoter hypermethylation in
mammary tumours. Breast Cancer Res. 10:R822008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kloten V, Becker B, Winner K, Schrauder
MG, Fasching PA, Anzeneder T, Veeck J, Hartmann A, Knüchel R and
Dahl E: Promoter hypermethylation of the tumor-suppressor genes
ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast
cancer screening. Breast Cancer Res. 15:R42013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xiang T, Li L, Yin X, Zhong L, Peng W, Qiu
Z, Ren G and Tao Q: Epigenetic silencing of the WNT antagonist
Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis
regulation in breast cancer cells. J Cell Mol Med. 17:1236–1246.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xiao Q, Wu J, Wang WJ, Chen S, Zheng Y, Yu
X, Meeth K, Sahraei M, Bothwell ALM, Chen L, et al: DKK2 imparts
tumor immunity evasion through β-catenin-independent suppression of
cytotoxic immune-cell activation. Nat Med. 24:262–270. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Aravalli RN, Talbot NC and Steer CJ: Gene
expression profiling of MYC-driven tumor signatures in porcine
liver stem cells by transcriptome sequencing. World J
Gastroenterol. 21:2011–2029. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Meng Q, Mongan M, Wang J and Xia Y:
Repression of MAP3K1 expression and JNK activity by canonical Wnt
signaling. Dev Biol. 440:129–136. 2018. View Article : Google Scholar : PubMed/NCBI
|
